introduction renal transplant is the best treatment of choice for patients with end-stage renal disease (1). annually, about 17000 patients receive deceased or living donor transplants, which help them promote health and self-efficacy (1-2). however, despite advances in transplant technology, patients face a number of post-operative challenges, which might lead to stress in patients, including ...

AIM Elucidate the incidence and causes of post transplant hypertension in our transplant population. METHODS All patients transplanted between June 1989 Dec 2002 who had a functioning graft of 6 months post transplant were studied. Hypertension was defined as Systolic BP > or = 140 mmHg/Diastolic BP > or = 90 mmHg/usage of antihypertensive medication. Donor and recepient characteristics were ...

Abstract Rituximab, an anti-CD20 agent, has been suggested as an effective strategy to deal with post transplant lymphoproliferative disorders (PTLD). In the current study, we aim to evaluate the efficacy of rituximab therapy in heart transplant population developing PTLD. A comprehensive search of the literature was performed to gather the available data on lymphoproliferative disorders oc...

We analyzed the frequency of vesicoureteral reflux and the factors that favor its appearance after kidney transplantation in pediatric patients. This retrospective analysis examined the prevalence of post-transplant vesicoureteral reflux in a total of 181 kidney transplants performed in children at our center between 1978 and 2004. In patients who required corrective surgery for this problem, w...

hypertension after pediatric renal transplant is a common and important risk factor for graft loss and patient survival. the mechanism of post kidney transplant hypertension is complex and multifactorial. control of blood pressure in renal transplant patients is important but often times blood pressures remain uncontrolled. the management of hypertension and obesity in pediatric kidney transpla...

Transplant patients are susceptible to a wide range of infections, one which includes Parvovirus B19 (PVB19). In post-renal transplant patient, due failure mount neutralising antibody response the virus, PVB19 causes significant morbidity & also graft dysfunction. It is usually present in first year post-transplant period, associated with anemia and nonspecific signs symptoms.

INTRODUCTION Decreased insulin sensitivity blunts the normal increase in gene expression from skeletal muscle after exercise. In addition, chronic inflammation decreases insulin sensitivity. Chronic kidney disease (CKD) is an inflammatory state. How CKD and, subsequently, kidney transplantation affects skeletal muscle gene expression after exercise are unknown. METHODS Study cohort: non-diabe...

Respiratory viral infections (RVI) are a frequent cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) patients. We examined clinical characteristics and respiratory viral detection in asymptomatic pediatric HSCT pre-transplant patients and symptomatic post-transplant patients. Coxsackie/echovirus (most common virus detected pre and post-transplant), rhinovirus, and cor...

With increasing use of high dose chemotherapy with autologous and allogeneic transplants the need for the transplant physician workforce requires reassessment. The types of transplants and patients are also shifting toward transplants being done in patients with more comorbidities and more commonly these types of patients require more work effort per patient from the transplant physician. Addit...

Infections are a major cause of morbidity andmortality in kidney transplant recipients. To some extent, these may be preventable. Careful pretransplant screening, immunization, and post-transplant prophylactic antimicrobials may all reduce the risk for post-transplant infection. However, because transplant recipients may not manifest typical signs and symptoms of infection, diagnoses may be con...